We are live on ! Find out more
CTSO icon

Cytosorbents Corp

38 hedge funds and large institutions have $7.66M invested in Cytosorbents Corp in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

356% more call options, than puts

Call options by funds: $1.43M | Put options by funds: $314K

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

15% more funds holding

Funds holding: 3338 (+5)

10% less capital invested

Capital invested by funds: $8.52M → $7.66M (-$857K)

Holders
38
Holders Change
+5
Holders Change %
+15.15%
% of All Funds
0.99%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
10
Reduced
6
Closed
8
Calls
$1.43M
Puts
$314K
Net Calls
+$1.12M
Net Calls Change
-$14K

CTSO Hedge Fund Activity: Q4 2015 in Review

38 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2015, worth a combined $7.66M — down 10% from $8.52M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CTSO positions and 8 closed out — a net gain of 5 holders — while 10 added to existing stakes and 6 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $187K. The largest seller was Raymond James & Associates, exiting entirely with an estimated $809K sold.

  • 38 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2015, up from 33 in Q3 2015.
  • Funds reported $7.66M of Cytosorbents Corp stock for Q4 2015, down 10% quarter-over-quarter.
  • 13 funds opened new Cytosorbents Corp positions in Q4 2015 and 8 closed out, a net change of +5 holders.
  • The largest Cytosorbents Corp buyer in Q4 2015 was Bank of Montreal, an estimated $187K added.
  • The largest Cytosorbents Corp seller in Q4 2015 was Raymond James & Associates, an estimated $809K sold.

Based on aggregated 13F filings for Q4 2015.